Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Boehringer Ingelheim Pharma Gmbh & Co Kg
FDA Inspection
•Boehringer Ingelheim Pharma Gmbh & Co Kg•April 5, 2019

Boehringer Ingelheim Pharma Gmbh & Co Kg – FDA Inspection, Apr 5, 2019

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on April 5, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Boehringer Ingelheim Pharma Gmbh & Co Kg
Inspection Date
April 5, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Doan N. Singh (Issuing Officer)
View Company Profile

ID · dbf348fc-bd1b-46d8-8ac0-0e7e2889aa61

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1086418
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

2
  1. 21 CFR 211.160(a)Lab controls established, including changes
  2. 21 CFR 211.192Investigations of discrepancies, failures

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Boehringer Ingelheim Pharma Gmbh & Co Kg

13
DateClassificationOfficeProject area
July 22, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 19, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
August 15, 2019NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
October 19, 2018Not classifiedOffice of Inspections and Investigations
September 21, 2018Not classifiedOffice of Inspections and Investigations
View all 13 other inspections on the company page
Other documents for Boehringer Ingelheim Pharma Gmbh & Co Kg
  • FDA Inspection 1208927 - 2022-07-22
  • FDA Inspection 1102691 - 2019-09-19
  • FDA Inspection 1107587 - 2019-08-15
  • FDA Inspection 1072835 - 2018-10-19
  • FDA Inspection 1069908 - 2018-09-21

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Pharma Gmbh & Co Kg
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.